Contribution of complement component C5 to the pathogenesis of experimental murine cryptococcosis

REFERENCES

• Diamond R.D., May J.E., Kane M., Frank M.M., Bennett J.E. The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Proceedings of the Society of Experimental Biology and Medicine 1973; 144: 312–315
   PubMed Web of Science ®Google Scholar
• Diamond R.D., May J.E., Kane M.A., Frank M.M., Bennett J.E. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. Journal of Immunology 1974; 112: 2260–2270
   PubMed Web of Science ®Google Scholar
• Emmons C.E., Binford C.H., Utz J.P., Kwon-Chung K.J. Medical Mycology. Lea & Febiger, Philadelphia 1977; 206–229
   Google Scholar
• Gadebusch H.H. Natural host resistance to infection with Cryptoccus neoformans. I. The effect of the properdin system on the experimental disease. Journal of Infectious Diseases 1961; 109: 147–153
   PubMed Web of Science ®Google Scholar
• Goldstein I.M., Perez H.D. Biologically active peptides derived from the fifth component of complement. Progress in Hemostasis and Thrombosis, T.H. Spaet. Grune & Stratton, New York 1980; 5: 41–79, In
   Google Scholar
• Graybill J.R., Ahrens J. Immunization and complement interaction in host defense against murine cryptococcosis. Journal of the Reticuloendothelial Society 1981; 30: 347–357
   PubMedGoogle Scholar
• Heidbrink P.J., Toews G.B., Gross G.N., Pierce A.K. Mechanisms of complement-mediated clearance of bacteria from the murine lung. American Review of Respiratory Diseases 1982; 125: 517–520
   PubMed Web of Science ®Google Scholar
• Hirano A., Zimmerman H.M., Levine S. The fine structure of cerebral fluid accumulation: reaction of ependyma to implantation of cryptococcal polysaccharide. Journal of Pathology and Bacteriology 1966; 91: 149–155
   PubMedGoogle Scholar
• Hosea S.W., Brown E.J., Frank M.M. The critical role of complement in experimental pneumococcal sepsis. Journal of Infectious Diseases 1980; 142: 903–909
   PubMed Web of Science ®Google Scholar
• Hosea S., Brown E., Hammer C., Frank M. Role of complement activation in a model of adult respiratory distress syndrome. Journal of Clinical Investigation 1980; 66: 375–382
   PubMed Web of Science ®Google Scholar
• Kozel T.R., Highison B., Stratton C.J. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infection and Immunity 1984; 43: 574–579
   PubMed Web of Science ®Google Scholar
• Kwon-Chung K.J. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 1976; 68: 821–833
   PubMed Web of Science ®Google Scholar
• Laxalt K.A., Kozel T.R. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans. Infection and Immunity 1979; 26: 435–440
   PubMed Web of Science ®Google Scholar
• Macher A.M., Bennett J.E., Gadek J.E., Frank M.M. Complement depletion in cryptococcal sepsis. Journal of Immunology 1978; 120: 1686–1690
   PubMed Web of Science ®Google Scholar
• Miller M.E., Nilsson U.R. A major role of the fifth component of complement (C5) in the opsonization of yeast particles. Partial dichotomy of function and immunochemical measurement. Clinical Immunology and Immunopathology 1974; 2: 246–255
   PubMedGoogle Scholar
• Rhodes J.C., Wicker L.S., Urba W.J. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infection and Immunity 1980; 29: 494–499
   PubMed Web of Science ®Google Scholar
• Snyderman R., Phillips J.K., Mergenhagen S.E. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. Journal of Experimental Medicine 1971; 134: 1131–1143
   PubMed Web of Science ®Google Scholar
• Snyderman R., Pike M.C., McCarley D., Lang L. Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity. Infection and Immunity 1975; 11: 488–492
   PubMed Web of Science ®Google Scholar
• Williams T.J., Jose P.J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. Journal of Experimental Medicine 1981; 153: 136–153
   PubMed Web of Science ®Google Scholar
• Wilson D.E., Bennett J.E., Bailey J.W. Serologic groupings of Cryptococcus neoformans. Proceedings of the Society of Experimental Biology and Medicine 1968; 127: 820–823
   PubMed Web of Science ®Google Scholar